Answers are grounded in this paper and cite their sources.
The log-rank test is a well-accepted non parametric test in comparing the survival time be- tween experimental and control group in regulatory settings. However, we have observed type I error inflation as high as 28% using the test in the simulation settings we have with even moderate sample sizes. In this paper, we explore several factors that potentially con- tribute to the inflation by simulation. Sample size, randomization ratio and significance levels are found to be influential factors. We propose an alternative log-rank test using an approximate permutation distribution instead of the standard normal distribution. It is shown that type I error is controlled when applying the approximate permutation test to both simple clinical trial designs and complicated group sequential designs.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: